This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.
This study exists to explore whether acceptance and commitment therapy, a talking treatment, could improve care and understanding. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.
In Huzhou
SchizophreniaBehavioralOver 60 Years
Countries
China
Sponsor
Third People's Hospital, Huzhou City, Zhejiang Province, China
This study is looking at better understand OCD (OCD) by examining the types and patterns of OCD symptom presentation for people with OCD or Schizophrenia and Schizophrenia Spectrum Psychosis. Participants are followed over time so researchers can learn from clinical and follow-up information.
Multiple locations, including Parma
OCD, SchizophreniaBehavioralFrom 18 Years to 65 Years
This study is completed in the United Kingdom, in Finland, and in Italy. It is testing OCTUMI-4: Evaluation of Mirtazapine and Folic Acid for schizophrenia.
In United Kingdom
SchizophreniaOther
Countries
United Kingdom, Finland, Italy
Sponsor
University of Oxford [...] 1. University of Oxford 2.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.